![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Maria Maddalena Cavalluzzi, Giuseppe Felice Mangiatordi, Orazio Nicolotti & Giovanni Lentini. (2017) Ligand efficiency metrics in drug discovery: the pros and cons from a practical perspective. Expert Opinion on Drug Discovery 12:11, pages 1087-1104.
Read now
Read now
Ana I. Loureiro, Maria João Bonifácio, Carlos Fernandes-Lopes, Nuno Pires, Bruno Igreja, Lyndon C. Wright & Patrício Soares-da-Silva. (2015) Role of P-glycoprotein and permeability upon the brain distribution and pharmacodynamics of etamicastat: a comparison with nepicastat. Xenobiotica 45:9, pages 828-839.
Read now
Read now
Deepak Dalvie, Amit S. Kalgutkar & Weichao Chen. (2015) Practical approaches to resolving reactive metabolite liabilities in early discovery. Drug Metabolism Reviews 47:1, pages 56-70.
Read now
Read now
Ziqiang Cheng, Houfu Liu, Na Yu, Fei Wang, Gang An, Yan Xu, Qian Liu, Chen-bing Guan & Andrew Ayrton. (2012) Hydrophilic anti-migraine triptans are substrates for OATP1A2, a transporter expressed at human blood-brain barrier. Xenobiotica 42:9, pages 880-890.
Read now
Read now
Dino Montanari, Elisabetta Chiarparin, Matthew Paul Gleeson, Simone Braggio, Raffaele Longhi, Klara Valko & Tino Rossi. (2011) Application of drug efficiency index in drug discovery: a strategy towards low therapeutic dose. Expert Opinion on Drug Discovery 6:9, pages 913-920.
Read now
Read now
Mario Pellegatti, Sabrina Pagliarusco, Lara Solazzo & Dimitri Colato. (2011) Plasma protein binding and blood-free concentrations: which studies are needed to develop a drug?. Expert Opinion on Drug Metabolism & Toxicology 7:8, pages 1009-1020.
Read now
Read now
Mario Pellegatti & Sabrina Pagliarusco. (2011) Drug and metabolite concentrations in tissues in relationship to tissue adverse findings: a review. Expert Opinion on Drug Metabolism & Toxicology 7:2, pages 137-146.
Read now
Read now
Laura Zonzini, Federica Bianchi, Nicola Cesari & Matteo Sartori. (2010) In vivo rat PK profiling in drug discovery: new challenges. Expert Opinion on Drug Discovery 5:11, pages 1031-1037.
Read now
Read now
Articles from other publishers (32)
Joaquim Trigo Marquês, Catarina Frazão De Faria, Marina Reis, Diana Machado, Susana Santos, Maria da Soledade Santos, Miguel Viveiros, Filomena Martins & Rodrigo F. M. De Almeida. (2022) In vitro Evaluation of Isoniazid Derivatives as Potential Agents Against Drug-Resistant Tuberculosis. Frontiers in Pharmacology 13.
Crossref
Crossref
Raquel Martinho, Gabriela Correia, Rafaela Seixas, Ana Oliveira, Soraia Silva, Paula Serrão, Carlos Fernandes-Lopes, Cristina Costa & Mónica Moreira-Rodrigues. (2021) Treatment With Nepicastat Decreases Contextual Traumatic Memories Persistence in Post-traumatic Stress Disorder. Frontiers in Molecular Neuroscience 14.
Crossref
Crossref
Aaron G. Poth, Francis C.K. Chiu, Sofie Stalmans, Brett R. Hamilton, Yen-Hua Huang, David M. Shackleford, Rahul Patil, Thao T. Le, Meng-Wei Kan, Thomas Durek, Evelien Wynendaele, Bart De Spiegeleer, Andrew K. Powell, Deon J. Venter, Richard J. Clark, Susan A. Charman & David J. Craik. (2021) Effects of backbone cyclization on the pharmacokinetics and drug efficiency of the orally active analgesic conotoxin cVc1.1. Medicine in Drug Discovery 10, pages 100087.
Crossref
Crossref
Randy R. Miller, Maria Madeira, Harold B. Wood, Wayne M. Geissler, Conrad E. Raab & Iain J. Martin. (2020) Integrating the Impact of Lipophilicity on Potency and Pharmacokinetic Parameters Enables the Use of Diverse Chemical Space during Small Molecule Drug Optimization. Journal of Medicinal Chemistry 63:21, pages 12156-12170.
Crossref
Crossref
Ammara Riaz, Azhar Rasul, Iqra Sarfraz, Javaria Nawaz, Ayesha Sadiqa, Rabia Zara, Samreen Gul Khan & Zeliha Selamoglu. 2020. Cheminformatics and its Applications. Cheminformatics and its Applications.
Klára L. Valkó. 2020. Separation Methods in Drug Synthesis and Purification. Separation Methods in Drug Synthesis and Purification
667
758
.
Saw Simeon, Dino Montanari & Matthew Paul Gleeson. (2019)
Investigation of Factors Affecting the Performance of
in silico
Volume Distribution QSAR Models for Human, Rat, Mouse, Dog & Monkey
. Molecular Informatics 38:10, pages 1900059.
Crossref
Crossref
Shenaz B. Bunally, Christopher N. Luscombe & Robert J. Young. (2019) Using Physicochemical Measurements to Influence Better Compound Design. SLAS Discovery 24:8, pages 791-801.
Crossref
Crossref
Vaibhav A. Dixit. (2019) A simple model to solve a complex drug toxicity problem. Toxicology Research 8:2, pages 157-171.
Crossref
Crossref
Serge Mignani, João Rodrigues, Helena Tomas, Rachid Jalal, Parvinder Pal Singh, Jean-Pierre Majoral & Ram A. Vishwakarma. (2018) Present drug-likeness filters in medicinal chemistry during the hit and lead optimization process: how far can they be simplified?. Drug Discovery Today 23:3, pages 605-615.
Crossref
Crossref
Simon Teague & Klara Valko. (2017) How to identify and eliminate compounds with a risk of high clinical dose during the early phase of lead optimisation in drug discovery. European Journal of Pharmaceutical Sciences 110, pages 37-50.
Crossref
Crossref
Fabrizio Micheli. (2017)
Novel, Selective, and Developable Dopamine D
3
Antagonists with a Modified “Amino” Region
. ChemMedChem 12:16, pages 1254-1260.
Crossref
Crossref
M.P. Gleeson & D. Montanari. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
64
93
.
M.M. Hann, M.K. Bayliss & A.R. Leach. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
560
576
.
Klára L. Valkó. (2016) Lipophilicity and biomimetic properties measured by HPLC to support drug discovery. Journal of Pharmaceutical and Biomedical Analysis 130, pages 35-54.
Crossref
Crossref
Serge Mignani, Scot Huber, Helena Tomás, João Rodrigues & Jean-Pierre Majoral. (2016) Compound high-quality criteria: a new vision to guide the development of drugs, current situation. Drug Discovery Today 21:4, pages 573-584.
Crossref
Crossref
J. Willem M. Nissink, Sebastien Degorce & Ken Page. 2016. Lead Generation. Lead Generation
451
486
.
Laurie J. Gordon, Morven Allen, Per Artursson, Michael M. Hann, Bill J. Leavens, André Mateus, Simon Readshaw, Klara Valko, Gareth J. Wayne & Andy West. (2016) Direct Measurement of Intracellular Compound Concentration by RapidFire Mass Spectrometry Offers Insights into Cell Permeability. SLAS Discovery 21:2, pages 156-164.
Crossref
Crossref
Ken M. Page. (2016) Validation of Early Human Dose Prediction: A Key Metric for Compound Progression in Drug Discovery. Molecular Pharmaceutics 13:2, pages 609-620.
Crossref
Crossref
Fabrizio Micheli, Susanna Cremonesi, Teresa Semeraro, Luca Tarsi, Silvia Tomelleri, Paolo Cavanni, Beatrice Oliosi, Elisabetta Perdonà, Anna Sava, Laura Zonzini, Aldo Feriani, Simone Braggio & Christian Heidbreder. (2016) Novel morpholine scaffolds as selective dopamine (DA) D3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters 26:4, pages 1329-1332.
Crossref
Crossref
Patrick Barton & Robert J. Riley. (2016) A new paradigm for navigating compound property related drug attrition. Drug Discovery Today 21:1, pages 72-81.
Crossref
Crossref
Alexander G. Shard, Rasmus Havelund, Steve J. Spencer, Ian S. Gilmore, Morgan R. Alexander, Tina B. Angerer, Satoka Aoyagi, Jean-Paul Barnes, Anass Benayad, Andrzej Bernasik, Giacomo Ceccone, Jonathan D. P. Counsell, Christopher Deeks, John S. Fletcher, Daniel J. Graham, Christian Heuser, Tae Geol Lee, Camille Marie, Mateusz M. Marzec, Gautam Mishra, Derk Rading, Olivier Renault, David J. Scurr, Hyun Kyong Shon, Valentina Spampinato, Hua Tian, Fuyi Wang, Nicholas Winograd, Kui Wu, Andreas Wucher, Yufan Zhou & Zihua Zhu. (2015) Measuring Compositions in Organic Depth Profiling: Results from a VAMAS Interlaboratory Study. The Journal of Physical Chemistry B 119:33, pages 10784-10797.
Crossref
Crossref
Elizabeth Kwong. (2015) Advancing Drug Discovery: A Pharmaceutics Perspective. Journal of Pharmaceutical Sciences 104:3, pages 865-871.
Crossref
Crossref
Michael M. Hann. 2015. Multifaceted Roles of Crystallography in Modern Drug Discovery. Multifaceted Roles of Crystallography in Modern Drug Discovery
183
196
.
Robert J. Young. 2015. Tactics in Contemporary Drug Design. Tactics in Contemporary Drug Design
1
68
.
Serge Mignani, Saïd El Kazzouli, Mosto Bousmina & Jean-Pierre Majoral. (2013) Dendrimer space concept for innovative nanomedicine: A futuristic vision for medicinal chemistry. Progress in Polymer Science 38:7, pages 993-1008.
Crossref
Crossref
Celerino Abad-Zapatero. 2013. Ligand Efficiency Indices for Drug Discovery. Ligand Efficiency Indices for Drug Discovery
49
62
.
Klara Valko, Elisabetta Chiarparin, Shenaz Nunhuck & Dino Montanari. (2012) In Vitro Measurement of Drug Efficiency Index to Aid Early Lead Optimization. Journal of Pharmaceutical Sciences 101:11, pages 4155-4169.
Crossref
Crossref
Michael M. Hann & György M. Keserü. (2012) Finding the sweet spot: the role of nature and nurture in medicinal chemistry. Nature Reviews Drug Discovery 11:5, pages 355-365.
Crossref
Crossref
Alleyn T. Plowright, Craig Johnstone, Jan Kihlberg, Jonas Pettersson, Graeme Robb & Richard A. Thompson. (2012) Hypothesis driven drug design: improving quality and effectiveness of the design-make-test-analyse cycle. Drug Discovery Today 17:1-2, pages 56-62.
Crossref
Crossref
Tino Rossi & Simone Braggio. (2011) Quality by Design in lead optimization: a new strategy to address productivity in drug discovery. Current Opinion in Pharmacology 11:5, pages 515-520.
Crossref
Crossref
Robert J. Young, Darren V.S. Green, Christopher N. Luscombe & Alan P. Hill. (2011) Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity. Drug Discovery Today 16:17-18, pages 822-830.
Crossref
Crossref